Marta Figueiredo holds a BSc in Biology and a MSc in Evolutionary and Developmental Biology from the University of Lisbon, Portugal. She is currently finishing her PhD in Biomedical Sciences at the University of Lisbon, where she focused her research on the role of several signalling pathways in thymus and parathyroid glands embryonic development.
Insmed’s brensocatib has been granted breakthrough therapy designation by the U.S. Food and Drug Administration (FDA) for the treatment of adults with non-cystic fibrosis bronchiectasis. The designation is given to ... Read more
Many bronchiectasis patients in Europe are not being tested for nontuberculous mycobacteria (NTM) infection before starting macrolide antibiotic treatment, as recommended by current guidelines, according to a small survey of ... Read more
People with non-cystic fibrosis (CF) bronchiectasis are at a significantly greater risk of exacerbations if they have chronic infections caused by Pseudomonas aeruginosa, a common bacteria that produces specific virulence factors, according to researchers ... Read more
Half of newly diagnosed patients with bronchiectasis in the U.S. also have chronic obstructive pulmonary disease (COPD), associated with a history of smoking and a higher number of hospitalizations, according ... Read more
Pin It on Pinterest